logo/base
Created with Sketch.
FibroScan
®
Discover FibroScan
®
FibroScan
®
Expert 630
FibroScan
®
Compact 530
FibroScan
®
Mini+ 430
FibroScan
®
GO
Scores
Discover Scores
Fast™
Agile 3+
Agile 4
myFibroScan
Pharma
Clinical Trials
White Paper
Liver Health
Understand Liver Health
MASLD / MASH
Alcoholic Liver Disease
Viral Hepatitis
Users
Essentials for Users
Examination Procedure
Covid-19
Probe and Machine Disinfection
VADoD
Market Access
Users Testimonials
echosensacademy.com
Patients
Information for Patients
Find a FibroScan
®
Act On Liver Health
About Us
Discover Echosens
Working at Echosens
Environmental, Social and Governance
Locate Us
en-us
Italiano
English CN
Español
Deutsch
Français
English
简体中文
Contact
Search
FibroScan
®
Discover FibroScan
®
FibroScan
®
Expert 630
FibroScan
®
Compact 530
FibroScan
®
Mini+ 430
FibroScan
®
GO
Scores
Discover Scores
Fast™
Agile 3+
Agile 4
myFibroScan
Pharma Solutions
Clinical Trials
White Paper
Clinical Evidence
Discover the Section
Clinical Library
International Guidelines
Liver Health
Understand Liver Health
MASLD / MASH
Alcoholic Liver Disease
Viral Hepatitis
Users
Essentials for Users
Examination Procedure
Covid-19
Probe and Machine Disinfection
VADoD
Market Access
Users Testimonials
echosensacademy.com
Patients
Information for Patients
Find a FibroScan
®
Act On Liver Health
Resources
Blog and News
Educational Videos
YouTube Channel
Podcasts
About Us
Discover Echosens
Working at Echosens
Patents
Trademarks
Locate Us
Contact Us
Support
English US version
Italiano
English CN
Español
Deutsch
Français
English
简体中文
Change region
Catégorie: Article
April 2021
HCV Treatments Can Cure Viral Infection, Not Neccessarily Liver Disease
April 2021
Answering the worldwide need for chronic liver disease assessment and diagnosis
April 2021
VA Tackles Liver Disease
April 2021
Non-Invasive Liver Assessment: Interview with Echosens’ New CEO Dominique Legros
April 2021
Follow-up of cirrhotic patients after etiologic treatment
Précédent
1
…
5
6
7
8